Overview

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

Status:
ENROLLING_BY_INVITATION

Trial end date:
2026-08-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to measure the frequency of menstrual irregularities among adolescent females with Type 1 diabetes mellitus and to assess the therapeutic effect of glucagon-like peptide-1 receptor agonist on menstrual irregularities in adolescent females with Type 1 diabetes mellitus .

Phase:

PHASE1

Details

Lead Sponsor:

Ain Shams University

Treatments:

dulaglutide